NASDAQ:ALHC - Alignment Healthcare Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $30.67
  • Forecasted Upside: 15.81 %
  • Number of Analysts: 7
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$26.48
▼ -0.79 (-2.90%)

This chart shows the closing price for ALHC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Alignment Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ALHC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ALHC

Analyst Price Target is $30.67
▲ +15.81% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Alignment Healthcare in the last 3 months. The average price target is $30.67, with a high forecast of $36.00 and a low forecast of $25.00. The average price target represents a 15.81% upside from the last price of $26.48.

This chart shows the closing price for ALHC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 7 investment analysts is to buy stock in Alignment Healthcare.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/31/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/25/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/24/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/18/2021Raymond JamesBoost Price TargetOutperform$30.00 ➝ $36.00Medium
4/20/2021Raymond JamesInitiated CoverageOutperform$30.00Low
4/20/2021Morgan StanleyInitiated CoverageOverweight$36.00Low
4/20/2021Bank of AmericaInitiated CoverageNeutral$29.00High
4/20/2021William BlairInitiated CoverageOutperformHigh
4/20/2021UBS GroupInitiated CoverageNeutral$28.00High
4/20/2021The Goldman Sachs GroupInitiated CoverageNeutral$25.00High
4/20/2021Piper SandlerInitiated CoverageOverweight$30.00High
(Data available from 6/23/2016 forward)
Alignment Healthcare logo
Alignment Healthcare, Inc. provides a consumer-centric platform that delivers customized health care to seniors in the United States. It offers medicare advantage plans and health plan options to its partners and patients with customized care and service; and preferred provider organization offerings. The company was founded in 2013 and is based in Orange, California.
Read More

Today's Range

Now: $26.48
Low: $26.30
High: $27.40

50 Day Range

MA: $24.49
Low: $20.57
High: $27.27

52 Week Range

Now: $26.48
Low: $16.32
High: $28.59

Volume

150,745 shs

Average Volume

434,761 shs

Market Capitalization

$4.96 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Alignment Healthcare?

The following Wall Street sell-side analysts have issued research reports on Alignment Healthcare in the last twelve months: Bank of America Co., Morgan Stanley, Piper Sandler, Raymond James, The Goldman Sachs Group, Inc., UBS Group AG, William Blair, and Zacks Investment Research.
View the latest analyst ratings for ALHC.

What is the current price target for Alignment Healthcare?

6 Wall Street analysts have set twelve-month price targets for Alignment Healthcare in the last year. Their average twelve-month price target is $30.67, suggesting a possible upside of 15.8%. Morgan Stanley has the highest price target set, predicting ALHC will reach $36.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $25.00 for Alignment Healthcare in the next year.
View the latest price targets for ALHC.

What is the current consensus analyst rating for Alignment Healthcare?

Alignment Healthcare currently has 3 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ALHC will outperform the market and that investors should add to their positions of Alignment Healthcare.
View the latest ratings for ALHC.

What other companies compete with Alignment Healthcare?

Other companies that are similar to Alignment Healthcare include Molina Healthcare, Clover Health Investments, Oscar Health, Trupanion and Advanzeon Solutions.

How do I contact Alignment Healthcare's investor relations team?

Alignment Healthcare's physical mailing address is 1100 W. TOWN AND COUNTRY ROAD SUITE 1600, ORANGE CA, 92868. The company's listed phone number is 844-310-2247 and its investor relations email address is [email protected] The official website for Alignment Healthcare is www.alignmenthealthcare.com.